The new biologics in psoriasis: possible treatments for alopecia areata

J Investig Dermatol Symp Proc. 2003 Oct;8(2):217-8. doi: 10.1046/j.1087-0024.2003.00813.x.

Abstract

Therapeutics in alopecia areata (AA) have remained relatively unchanged for many years, with few treatments having more than moderate effects in severely affected patients. The advent of the new biologic medications in the dermatologic world, however, particularly in psoriasis treatment, introduces possibilities of treatment for many other immune-mediated diseases.

MeSH terms

  • Alefacept
  • Alopecia Areata / therapy*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Immunologic Factors / therapeutic use*
  • Psoriasis / therapy*
  • Recombinant Fusion Proteins / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Alefacept
  • efalizumab